Cargando…

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target

Molecular markers for predicting prognosis of colorectal cancer (CRC) patients are urgently needed for effective disease management. We reported previously that the multifunctional enzyme Transglutaminase 2 (TGM2) is essential for CRC cell survival by inactivation of the tumor suppressor p53. Based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malkomes, Patrizia, Lunger, Ilaria, Oppermann, Elsie, Lorenz, Johannes, Faqar-Uz-Zaman, Sara Fatima, Han, Jiaoyan, Bothur, Sabrina, Ziegler, Paul, Bankov, Katrin, Wild, Peter, Bechstein, Wolf Otto, Rieger, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581896/ https://www.ncbi.nlm.nih.gov/pubmed/37443286 http://dx.doi.org/10.1038/s41417-023-00641-y

Ejemplares similares

Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
por: Malkomes, Patrizia, et al.
Publicado: (2021)

Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells
por: Malkomes, Patrizia, et al.
Publicado: (2016)

A toolbox for a structured risk-based prehabilitation program in major surgical oncology
por: Sliwinski, Svenja, et al.
Publicado: (2023)

Study protocol for a pilot trial analysing the usability, validity and safety of an interventional health app programme for the structured prehabilitation of patients before major surgical interventions: the PROTEGO MAXIMA trial
por: Faqar-Uz-Zaman, Sara Fatima, et al.
Publicado: (2023)

Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial
por: Faqar-Uz-Zaman, S Fatima, et al.
Publicado: (2021)

S1P Lyase Regulates Intestinal Stem Cell Quiescence via Ki-67 and FOXO3
por: Schwiebs, Anja, et al.
Publicado: (2021)

DIALAPP: a prospective validation of a new diagnostic algorithm for acute appendicitis
por: Malkomes, Patrizia, et al.
Publicado: (2020)

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis
por: Koll, Florestan J., et al.
Publicado: (2023)

Neurolymphomatosis – Rare presentation in non-Hodgkin’s lymphoma: The role of (18)F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging
por: Fatima, Nosheen, et al.
Publicado: (2020)

Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma
por: Bankov, Katrin, et al.
Publicado: (2018)

Biotechnological Applications of Transglutaminases
por: Rachel, Natalie M., et al.
Publicado: (2013)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

Transglutaminase in neurological disease
por: Hoffner, Guylaine, et al.
Publicado: (2017)

Transglutaminase in Foods and Biotechnology
por: Vasić, Katja, et al.
Publicado: (2023)

Anti Transglutaminase Antibodies Cause Ataxia in Mice
por: Boscolo, Sabrina, et al.
Publicado: (2010)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Biological Functionalities of Transglutaminase 2 and the Possibility of Its Compensation by Other Members of the Transglutaminase Family
por: Odii, Benedict Onyekachi, et al.
Publicado: (2014)

Identification of Chicken Transglutaminase 1 and In Situ Localization of Transglutaminase Activity in Avian Skin and Esophagus
por: Sachslehner, Attila Placido, et al.
Publicado: (2021)

Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics
por: Fatima, Syeda Warisul, et al.
Publicado: (2021)

Transglutaminase 2 in human diseases
por: Szondy, Zsuzsa, et al.
Publicado: (2017)

Transglutaminase Modification of Tendon Collagen
por: Gross, Christopher E., et al.
Publicado: (2022)

Wandering Meckel's diverticulum on 99m technetium-pertechnetate scintigraphy: A diagnostic dilemma?
por: uz Zaman, Maseeh, et al.
Publicado: (2014)

Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells
por: Juratli, Mazen A., et al.
Publicado: (2022)

How to learn with intentional mistakes: NoisyEnsembles to overcome poor tissue quality for deep learning in computational pathology
por: Mayer, Robin S., et al.
Publicado: (2022)

Comparison of Hemodynamic Effects and Negative Predictive Value of Normal Adenosine Gated Myocardial Perfusion Scan With or Without Caffeine Abstinence
por: uz Zaman, Maseeh, et al.
Publicado: (2016)

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)

Giant cystic parathyroid adenoma with thrombosis of internal jugular vein seen on CT and Tc-99m methoxy isobutyl isonitrile parathyroid scan
por: Zaman, Maseeh uz, et al.
Publicado: (2012)

Diagnostic Challenges in Prostate Cancer and (68)Ga-PSMA PET Imaging: A Game Changer?
por: Zaman, Maseeh uz, et al.
Publicado: (2017)

Massive Tumor Thrombus in Left Renal Vein and Inferior Vena Cava in Renal Cell Carcinoma on 18-fluorodeoxyglucose Positron Emission Tomography/computerized Tomography: “Suspension Bridge Sign”
por: Zaman, Maseeh Uz, et al.
Publicado: (2018)

Higher event rate in patients with high-risk Duke Treadmill Score despite normal exercise-gated myocardial perfusion imaging
por: Zaman, Maseeh uz, et al.
Publicado: (2018)

Predictors of metabolic response in propensity-matched lymphoma patients on interim (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography using standardized imaging and reporting protocol: Do we really have one?
por: Fatima, Nosheen, et al.
Publicado: (2019)

Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using (18)FDG PET/CT with Standardized Protocol
por: Fatima, Nosheen, et al.
Publicado: (2019)

Detection efficiency of (18)F-flourodeoxyglucose positron emission tomography/computed tomography for primary tumors in patients with carcinoma of unknown primary
por: Fatima, Nosheen, et al.
Publicado: (2019)

Progression Free Survival and Predictor of Recurrence in DLBCL patients with Negative Interim (18)FDG PET/CT Using Standardized Imaging and Reporting Protocols
por: Zaman, Maseeh uz, et al.
Publicado: (2020)

Impact of Primary Tumor Size, SUVmax of Primary Tumor and the Most Avid Neck Node on Baseline (18) FDG PET/CT upon Disease Recurrence in Head and Neck Oropharyngeal SCC Using Standardized Imaging Protocol
por: Fatima, Nosheen, et al.
Publicado: (2022)

A Tertiary Twist to the Transglutaminase Tale
por: Koning, Frits
Publicado: (2007)

Activation and Inhibition of Transglutaminase 2 in Mice
por: Dafik, Laila, et al.
Publicado: (2012)

Exercise, Vascular Stiffness, and Tissue Transglutaminase
por: Steppan, Jochen, et al.
Publicado: (2014)

Regulation of Pollen Tube Growth by Transglutaminase
por: Cai, Giampiero, et al.
Publicado: (2013)

Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_23vrabgckbf2nglgnufqcv8ifo